Key result
CABG linked to ~25% fewer major events vs PCI in CAC>1000, driven by fewer MIs.
Why the study?
Benefits of CABG versus PCI for stable CAD may depend on total plaque burden alongside stenosis count, so the authors investigated whether coronary artery calcification predicts CABG versus PCI benefits.
Does CABG reduce the risk of death, myocardial infarction, or stroke compared to PCI in patients with stable CAD stratified by coronary artery calcification (CAC) burden?
Does CABG reduce the risk of death, myocardial infarction, or stroke compared to PCI in patients with stable CAD stratified by coronary artery calcification (CAC) burden?
In patients with stable CAD and high coronary plaque burden (CAC >1000), CABG is associated with a lower long-term risk of death, MI, or stroke compared to PCI.
CABG was associated with lower events at CAC>1000; observational data leaves open need for randomized confirmation.
Benefits of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) for patients with stable coronary artery disease (CAD) may be determined by total plaque burden alongside number of stenoses. We aimed to determine whether coronary artery calcification (CAC), reflecting overall plaque burden, predicts CABG versus PCI benefits. Among 85,512 symptomatic patients undergoing computed tomography angiography, we conducted propensity-matched analyses. CABG-treated patients (n = 1,479) were 1:1:1 matched with PCI-treated patients and non-obstructive CAD patients. Cox proportional hazard models assessed risk for the primary endpoint (death, myocardial infarction, stroke), stratified by CAC<300, CAC 300-1000, and CAC>1000. Over 5.3 years, 710 primary endpoints occurred. CABG patients had higher prevalence of three-vessel obstructive CAD compared to PCI-treated patients (30 %vs.18 %). Event rates rose with increasing CAC scores; CAC<300 indicated low risk, CAC>1000 indicated very-high risk. Patients with non-obstructive CAD had similar risk to PCI-revascularized patients across CAC groups. Compared to PCI, risk for the primary endpoint were lower at higher plaque burden in CABG-treated patients with hazard ratios of 1.12 (95 %CI 0.70-1.80), 0.82 (95 %CI 0.55-1.20), and 0.75 (95 %CI 0.58-0.94) for CAC<300, CAC 300-1000, and CAC>1000, respectively. The lower CABG-associated risk was driven by reduced myocardial infarction risk (HR 0.44 (95 %CI 0.26-0.73)). Among patients with high, but not low, coronary plaque burden, CABG yielded lower long-term risk than PCI, despite more multivessel obstructive CAD. This suggest that the benefit of CABG over PCI for patients with extensive CAD can, at least partly, be attributed to the bypassing of a larger plaque burden. Among patients with high, but not low, coronary plaque burden as assessed by coronary artery calcification, revascularization with coronary artery bypass grafting is associated with lower long-term risk than percutaneous coronary intervention despite higher prevalence of multivessel obstructive disease.
No takes yet. Share an insight, caveat, or question.
Mortensen et al. (2026) studied this question. In patients with high coronary plaque burden (CAC>1000), CABG reduced the primary endpoint risk by 25% versus PCI (HR 0.75, 95% CI 0.58-0.94), mainly via MI reduction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: